Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Prothena Corp
(NQ:
PRTA
)
21.71
+0.46 (+2.16%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Prothena Corp
< Previous
1
2
3
4
5
6
7
Next >
4 Analysts Have This to Say About Prothena Corp
December 18, 2023
Via
Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
November 21, 2023
Recent advancements in Alzheimer's disease treatments targeting the removal of toxic proteins (white matter) from the brain have sparked a renewed interest in developing vaccines to combat this
Via
Benzinga
Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning
November 17, 2023
Biotech companies are edging closer to finding the answers behind Alzheimer's disease.
Via
Investor's Business Daily
8 Health Care Stocks Whale Activity In Today's Session
November 07, 2023
Via
Benzinga
Prothena Reports Third Quarter 2023 Financial Results and Business Highlights
November 02, 2023
From
Prothena Corporation plc
Via
Business Wire
Earnings Preview For Prothena Corp
November 01, 2023
Via
Benzinga
Expert Ratings for Prothena Corp
October 23, 2023
Via
Benzinga
Expert Ratings for Prothena Corp
August 22, 2023
Via
Benzinga
Prothena to Report Third Quarter 2023 Financial Results on November 2
October 26, 2023
From
Prothena Corporation plc
Via
Business Wire
Biogen Pulls Prothena Into A Steep Dive On Mixed Results For Alzheimer's Treatment
October 26, 2023
Both companies are working on under-the-skin injections for Alzheimer's treatment.
Via
Investor's Business Daily
Lululemon, PCTEL, Consolidated Communications, Other Stocks Jumping Higher On Monday
October 16, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 350 points on Monday. Here are some stocks recording big gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
JMP Securities Maintains Outperform Rating for Prothena Corp: Here's What You Need To Know
August 04, 2023
Via
Benzinga
Earnings Scheduled For August 3, 2023
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via
Benzinga
Prothena Corp's Earnings Outlook
August 02, 2023
Via
Benzinga
Expert Ratings for Prothena Corp
July 11, 2023
Via
Benzinga
8 Analysts Have This to Say About Prothena Corp
June 21, 2023
Via
Benzinga
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 16, 2023
Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday.
Via
Benzinga
Why Is Alzheimer's Player Prothena Stock Trading Higher Today?
October 16, 2023
Prothena Corporation plc (NASDAQ: PRTA) is reportedly talking to advisors, potentially preparing for a sale.
Via
Benzinga
Looking Into Prothena Corp's Return On Capital Employed
May 16, 2023
Via
Benzinga
Recap: Prothena Corp Q1 Earnings
May 04, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
October 05, 2023
On Thursday, 369 companies hit new 52-week lows.
Via
Benzinga
Prothena to Participate in Upcoming Healthcare Conferences
August 31, 2023
From
Prothena Corporation plc
Via
Business Wire
Prothena Reports Second Quarter 2023 Financial Results and Business Highlights
August 03, 2023
From
Prothena Corporation plc
Via
Business Wire
Prothena to Report Second Quarter 2023 Financial Results on August 3
July 27, 2023
From
Prothena Corporation plc
Via
Business Wire
Prothena Presents New Research in the Treatment of Alzheimer’s Disease at Alzheimer’s Association International Conference® 2023 (AAIC®)
July 17, 2023
From
Prothena Corporation plc
Via
Business Wire
Prothena to Present New Data from Alzheimer’s Disease Programs at Alzheimer’s Association International Conference® 2023 (AAIC®)
July 11, 2023
From
Prothena Corporation plc
Via
Business Wire
Prothena Announces Bristol Myers Squibb Opt-in for Worldwide Rights of PRX005, a Novel Anti-MTBR-Tau Antibody
July 10, 2023
From
Prothena Corporation plc
Via
Business Wire
Prothena Announces Phase 3 VITAL Clinical Trial Results Published in Blood Showing Survival Benefit in Patients with Mayo Stage IV AL Amyloidosis Treated with Birtamimab
June 27, 2023
From
Prothena Corporation plc
Via
Business Wire
Prothena to Participate in Jefferies 2023 Healthcare Conference
June 02, 2023
From
Prothena Corporation plc
Via
Business Wire
Prothena Announces Appointment of Billy Dunn, M.D., to its Board of Directors
May 16, 2023
From
Prothena Corporation plc
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.